Mydecine Innovations Group is a biotechnology company that develops a novel therapeutics to treat mental health and addiction disorders.
Mydecine Innovations Group has raised $3.8M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in September 2023.
Mydecine Innovations Group is headquartered in Vancouver, Canada.
Mydecine Innovations Group is a biotechnology company that develops a novel therapeutics to treat mental health and addiction disorders.
Mydecine Innovations Group is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Mydecine Innovations Group — Funding & Investors." VCBacked, September 15, 2023, https://www.vcbacked.co/company/mydecine-innovations-group. Accessed August 13, 2026.
VCBacked. (2023). Mydecine Innovations Group — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/mydecine-innovations-group
{{cite web |title=Mydecine Innovations Group — Funding & Investors |url=https://www.vcbacked.co/company/mydecine-innovations-group |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated